These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25604548)

  • 21. CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.
    Carotenuto A; Scalia G; Ausiello F; Moccia M; Russo CV; Saccà F; De Rosa A; Criscuolo C; Del Vecchio L; Brescia Morra V; Lanzillo R
    J Neuroimmunol; 2017 Aug; 309():47-50. PubMed ID: 28601287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint inhibitors: A potential bright spot in the treatment of progressive multifocal leukoencephalopathy in multiple sclerosis.
    Motte J; Gold R
    Mult Scler; 2023 Feb; 29(2):306-307. PubMed ID: 36451582
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
    O'Connor PW; Kremenchutzky M
    Can J Neurol Sci; 2015 Nov; 42(6):372-80. PubMed ID: 26503087
    [No Abstract]   [Full Text] [Related]  

  • 24. Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
    Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C
    N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological and clinical consequences of treating a patient with natalizumab.
    Schwab N; Höhn KG; Schneider-Hohendorf T; Metz I; Stenner MP; Jilek S; Du Pasquier RA; Gold R; Meuth SG; Ransohoff RM; Brück W; Wiendl H
    Mult Scler; 2012 Mar; 18(3):335-44. PubMed ID: 21908480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natalizumab in the treatment of patients with multiple sclerosis: first experience.
    Mareckova H; Havrdova E; Krasulova E; Vankova Z; Koberová M; Sterzl I
    Ann N Y Acad Sci; 2007 Sep; 1110():465-73. PubMed ID: 17911462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.
    Kleinschmidt-DeMasters BK; Miravalle A; Schowinsky J; Corboy J; Vollmer T
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):604-17. PubMed ID: 22710964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient.
    Massey TH; Smith R; Sadiq S; Overton C; Pearson OR
    Neurology; 2017 Feb; 88(7):711-713. PubMed ID: 28077489
    [No Abstract]   [Full Text] [Related]  

  • 29. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
    Schippling S; Kempf C; Büchele F; Jelcic I; Bozinov O; Bont A; Linnebank M; Sospedra M; Weller M; Budka H; Martin R
    Ann Neurol; 2013 Oct; 74(4):622-6. PubMed ID: 23868420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy.
    Bartt RE
    Curr Opin Neurol; 2006 Aug; 19(4):341-9. PubMed ID: 16914971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.
    Dang X; Koralnik IJ
    Ann Neurol; 2013 Oct; 74(4):503-5. PubMed ID: 23913509
    [No Abstract]   [Full Text] [Related]  

  • 32. Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
    Warnke C; Mausberg AK; Stettner M; Dehmel T; Nekrich L; Meyer zu Horste G; Hartung HP; Fogdell-Hahn A; Adams O; Kieseier BC
    Neurology; 2013 Oct; 81(16):1400-8. PubMed ID: 24049136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
    Baldwin KJ; Hogg JP
    Curr Opin Neurol; 2013 Jun; 26(3):318-23. PubMed ID: 23493158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
    Jilek S; Jaquiéry E; Hirsch HH; Lysandropoulos A; Canales M; Guignard L; Schluep M; Pantaleo G; Du Pasquier RA
    Lancet Neurol; 2010 Mar; 9(3):264-72. PubMed ID: 20117055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literature.
    Young BE; Yeo TR; Lim HT; Vong KY; Tan K; Lye DC; Lee CC
    Ann Acad Med Singap; 2012 Dec; 41(12):620-4. PubMed ID: 23303123
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.
    Schröder A; Lee DH; Hellwig K; Lukas C; Linker RA; Gold R
    Arch Neurol; 2010 Nov; 67(11):1391-4. PubMed ID: 20625069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV.
    Lisco A; Lange C; Manion M; Kuriakose S; Dewar R; Gorelick RJ; Huik K; Yu Q; Hammoud DA; Smith BR; Muranski P; Rehm C; Sherman BT; Sykes C; Lindo N; Ye P; Bricker KM; Keele BF; Fennessey CM; Maldarelli F; Sereti I
    Nat Med; 2023 Jun; 29(6):1364-1369. PubMed ID: 37322122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
    Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
    Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
    Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS
    Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.